C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/00 (2006.01) C07K 16/28 (2006.01) C12N 15/11 (2006.01) G01N 33/569 (2006.01) C12N 9/10 (2006.01) C12N 9/24 (2006.01)
Patent
CA 2717614
The present invention concerns a mammalian cell lacking G1cNAc transferase I activity, engineered to express an antibody or a fragment thereof, thereby enhancing the antibody dependent cell mediated cytotoxicity (ADCC) exhibited by the expressed antibody or fragment thereof.
La présente invention concerne une cellule mammifère ne présentatn pas d'activité de transférase I GlcNAc, conçue pour exprimer un anticorps ou un de ses fragments, tout en améliorant la cytotoxicité à médiation cellulaire dépendante d'un anticorps (ADCC) exposée dans l'anticorps exprimé ou son fragment.
Bayer Robert
Harris Reed J.
Li Feng
Ng Domingos
Pacis Efren
Genentech Inc.
Smart & Biggar
LandOfFree
Antibodies with enhanced adcc function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies with enhanced adcc function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies with enhanced adcc function will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1888433